Complete ICD-10-CM coding and documentation guide for Abnormal PSA. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Complete code families applicable to Abnormal PSA
Abnormal tumor markers
This range includes codes for abnormal findings of tumor markers, specifically for elevated PSA levels.
Compare key differences between these codes to ensure accurate selection
Code | Description | When to Use | Key Documentation |
---|---|---|---|
R97.20 | Elevated prostate specific antigen [PSA] | Use for elevated PSA levels when there is no confirmed diagnosis of prostate cancer or other specific conditions. |
|
R97.21 | Rising PSA following treatment for malignant neoplasm of prostate | Use for rising PSA levels in patients with a history of prostate cancer treatment. |
|
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Essential facts and insights about Abnormal PSA
Use for rising PSA levels in patients with a history of prostate cancer treatment.
Ensure documentation includes treatment history and PSA trends.
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Encounter for screening for malignant neoplasm of prostate
Z12.5Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Avoid these common documentation and coding issues when documenting Abnormal PSA to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code R97.20.
Clinical: May lead to inappropriate follow-up or treatment., Regulatory: Potential for audit issues., Financial: Risk of claim denials.
Include specific PSA values, Document clinical context
Reimbursement: Incorrect coding can lead to claim denials., Compliance: Non-compliance with Medicare guidelines., Data Quality: Inaccurate data on screening vs. diagnostic PSA tests.
Use Z12.5 with G0103 for screening purposes.
Incorrect coding of PSA tests as diagnostic when they are screening.
Educate staff on correct code usage and documentation requirements.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Common questions about ICD-10 coding for Abnormal PSA, with expert answers to help guide accurate code selection and documentation.
Use these documentation templates to ensure complete and accurate documentation for Abnormal PSA. These templates include all required elements for proper coding and billing.
Need help with ICD-10 coding for Abnormal PSA? Ask your questions below.